These findings will help scientists understand how to better diagnose and treat the disease.
Oklahoma City
OMRF researcher tests new approach for treating deadly blood infection
Lupu’s findings were published in the Proceedings of the National Academy of Sciences.
Military academy students get hands-on lab experience at OMRF
The Saxon program provides military academy students with an opportunity to work alongside OMRF senior scientists.
OMRF receives new grants to study blood clotting, ovarian cancer
The National Institutes of Health grants total nearly $2.1 million.
Q BioMed Inc. finalizes license agreement with OMRF, RGCB
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
The best Father’s Day gift: A healthy heart
Heart disease is the leading cause of death for men in the U.S., killing one in every four males.
